Alfuzosin hydrochlorideProduct ingredient for Alfuzosin

Name
Alfuzosin hydrochloride
Drug Entry
Alfuzosin

Benign prostatic hyperplasia (BPH) refers to a benign growth or hyperplasia of the prostate and leads to lower urinary tract symptoms in men, such as urgency, frequency and changes to urine flow. The prevalence of BPH is as high as 50%-60% for males in their 60's, and this prevalence increases to 80%-90% of those over 70.6 Alfuzosin is an alpha-1 adrenergic blocker used in the symptomatic treatment of BPH that works by relaxing the muscles in the prostate and bladder neck.10 It was initially approved by the FDA in 2003 and is marketed by several pharmaceutical companies.9

Accession Number
DBSALT001063
Structure
Synonyms
Alfuzosin HCl
UNII
75046A1XTN
CAS Number
81403-68-1
Weight
Average: 425.91
Monoisotopic: 425.1829821
Chemical Formula
C19H28ClN5O4
InChI Key
YTNKWDJILNVLGX-UHFFFAOYSA-N
InChI
InChI=1S/C19H27N5O4.ClH/c1-24(8-5-7-21-18(25)14-6-4-9-28-14)19-22-13-11-16(27-3)15(26-2)10-12(13)17(20)23-19;/h10-11,14H,4-9H2,1-3H3,(H,21,25)(H2,20,22,23);1H
IUPAC Name
N-{3-[(4-imino-6,7-dimethoxy-3,4-dihydroquinazolin-2-yl)(methyl)amino]propyl}oxolane-2-carboximidic acid hydrochloride
SMILES
Cl.COC1=C(OC)C=C2C(=N)NC(=NC2=C1)N(C)CCCN=C(O)C1CCCO1
ChemSpider
64803
ChEBI
32286
ChEMBL
CHEMBL1723
Wikipedia
Alfuzosin
Predicted Properties
PropertyValueSource
Water Solubility0.146 mg/mLALOGPS
logP1.37ALOGPS
logP-0.041Chemaxon
logS-3.4ALOGPS
pKa (Strongest Acidic)2.26Chemaxon
pKa (Strongest Basic)5.56Chemaxon
Physiological Charge0Chemaxon
Hydrogen Acceptor Count9Chemaxon
Hydrogen Donor Count3Chemaxon
Polar Surface Area111.76 Å2Chemaxon
Rotatable Bond Count8Chemaxon
Refractivity118.18 m3·mol-1Chemaxon
Polarizability42.21 Å3Chemaxon
Number of Rings3Chemaxon
Bioavailability1Chemaxon
Rule of FiveYesChemaxon
Ghose FilterYesChemaxon
Veber's RuleNoChemaxon
MDDR-like RuleYesChemaxon